Geetika Sethi, Ph.D.
Affiliations: | 2013 | Biochemistry and Molecular Biology | Drexel University College of Medicine, Philadelphia, PA, United States |
Area:
Molecular Biology, Biostatistics BiologyGoogle:
"Geetika Sethi"Parents
Sign in to add mentor| Andrew K. Godwin | grad student | 2013 | Drexel Medical School | |
| (An RNA interference Lethality Screen of the Human Druggable Genome to Identify Molecular Vulnerabilities in Epithelial Ovarian Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Radovich M, Pickering CR, Felau I, et al. (2018) The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 33: 244-258.e10 |
| Pathak HB, Zhou Y, Sethi G, et al. (2015) A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer. Plos One. 10: e0144126 |
| Sethi G, Kwon Y, Burkhalter RJ, et al. (2014) PTN signaling: Components and mechanistic insights in human ovarian cancer. Molecular Carcinogenesis |
| Sharma P, Stecklein SR, Kimler BF, et al. (2014) The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer. Journal of Cancer Therapeutics & Research. 3: 1-11 |
| Atay S, Banskota S, Crow J, et al. (2014) Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 111: 711-6 |
| Pessetto ZY, Weir SJ, Sethi G, et al. (2013) Drug repurposing for gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 12: 1299-309 |
| Sethi G, Pathak H, Zhang H, et al. (2013) Abstract A06: Integration of synthetic lethality and genomic data to identify significant molecular vulnerabilities in ovarian cancer Molecular Cancer Therapeutics. 12 |
| Sethi G, Pathak HB, Zhang H, et al. (2012) An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. Plos One. 7: e47086 |
| Somasundaram RT, Ramalingam S, Subramaniam D, et al. (2012) Abstract 433: Expression of stem cell and EMT markers on circulating tumor cells Cancer Research. 72: 433-433 |
| Sethi G, Pathak HB, Zhang H, et al. (2011) Abstract 4969: RNA interference screens to identify genes essential for ovarian tumor growth and maintenance Cellular and Molecular Biology. 71: 4969-4969 |